Genitourinary Cancer News

Investigators from Georgetown University Medical Center and Fudan University in China have developed a novel noninvasive and individualized technique for the detection and treatment of bladder cancer.

Three scientists — two from the United States and one from England — the Nobel Prize in Medicine or Physiology for their discoveries of how cells sense and adapt to oxygen availability.

BARCELONA, Spain — Circulating tumor DNA detected through liquid biopsy appeared to be an independent prognostic marker for identifying patients with colorectal cancer who are likely to relapse after surgery, according to results of a phase 3 trial presented at European Society for Medical Oncology Congress.

BARCELONA, Spain — The addition of atezolizumab to chemotherapy prolonged PFS for patients with metastatic urothelial cancer, according to results of a randomized phase 3 study presented at European Society for Medical Oncology Congress.

A novel therapeutic approach that involves the oncolytic virus coxsackievirus showed potential among a small cohort of patients with nonmuscle-invasive bladder cancer, according to study findings published in Clinical Cancer Research.

The Seattle Cancer Care Alliance, the clinical care partner of the Fred Hutchinson Cancer Research Center, has been at the forefront of cellular therapies for cancer treatment since the field emerged. It was there where E. Donnall Thomas, MD, and his team pioneered the use of bone marrow transplant during the 1970s and SCCA’s position remains unchanged in the field of cellular therapies as its research and clinical staff have administered more CAR T-cell therapies to patients than any other facility in the world.

The American Association for Cancer Research today released its annual Cancer Progress Report, which reflects how prior investment in the NIH is paying dividends in terms of advances across the spectrum of cancer care.

The FDA granted priority review to enfortumab vedotin for treatment of certain patients with locally advanced or metastatic urothelial cancer.

BARCELONA — The International Association for the Study of Lung Cancer, or IASLC, today issued a declaration at its World Conference on Lung Cancer advising all physicians to screen their patients with cancer for tobacco use and recommend tobacco cessation.

Oncologic randomized clinical trials published between 2003 and 2018 exhibited a low rate of female corresponding authorship in relation to the overall percentage of female academic oncologists during the period, according to a research letter published in JAMA Oncology.